Patient and public involvement in the co-design of a multicenter randomized controlled trial on prehabilitation: results from the PREHAB-PEER conceptual phase.

Eur J Surg OncolJul 28, 2026 (epub)

Magdalena Holze, Solveig Tenckhoff, Eva Kalkum et al.

✦ AI-curated · Sources linked

In 30 seconds

This study focused on the co-design of a multicenter randomized controlled trial (RCT) for prehabilitation in colorectal cancer (CRC) patients. Involving patients and stakeholders, the research aimed to create a patient-centered trial design addressing perioperative risks. The primary endpoint selected was Quality of Recovery, emphasizing the importance of patient input in trial development.

Key findings

  • A patient-centered study design was developed for the PREHAB-PEER RCT over 12 months.
  • The target population includes CRC patients with increased perioperative risk based on age, frailty, and nutrition status.
  • Quality of Recovery was chosen as the primary endpoint for the trial.

Why it matters

Incorporating patient and stakeholder perspectives in trial design can enhance the relevance and feasibility of clinical research, ultimately leading to improved patient outcomes and adherence in complex interventions like prehabilitation.

Source

Published in Eur J Surg Oncol. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Oncology (Medical)

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.